Literature DB >> 728999

Lack of correlation between the decreased expression of cell surface LETS protein and tumorigenicity in human cell hybrids.

C J Der, E J Stanbridge.   

Abstract

An analysis of the correlation between tumorigenicity and the loss of expression of the large external transformation-sensitive glycoprotein (LETS) was performed on human cell hybrids and their respective normal and tumorigenic parental cell lines. The distribution of cell surface LETS protein in a series of cell lines was examined by both specific immunofluorescent staining and by gel electrophoresis of lactoperoxidase-catalyzed, iodinated cell surface proteins. The tumorigenicity of these cell lines was assayed in nude mice. Although the series of cell lines studied provided a broad spectrum of LETS protein expression, both quantitatively and qualitatively, there does not appear to be a correlation between tumorigenicity and decreased expression of the LETS protein. In a series of transformed, nontumorigenic hybrids, the LETS protein expression was found to be altered with respect to both decreased organizational complexity and decreased content. These hybrids continue to express a number of other transformed phenotypes. Conversely, a number of tumorigenic hybrids continue to express relatively high levels of LETS protein when compared with nontumorigenic hybrids. Thus an alteration in LETS protein expression by itself, or in concert with a spectrum of other transformation properties, does not appear to be a sufficient requirement for tumorigenicity and lends further support to an apparent separate control of the transformed versus tumorigenic phenotype.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 728999     DOI: 10.1016/0092-8674(78)90050-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  14 in total

1.  Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells.

Authors:  F X Bosch; E Schwarz; P Boukamp; N E Fusenig; D Bartsch; H zur Hausen
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Localization of HeLa cell tumor-suppressor gene to the long arm of chromosome II.

Authors:  B C Misra; E S Srivatsan
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

3.  Isolation and characterization of a highly enriched preparation of receptosomes (endosomes) from a human cell line.

Authors:  R B Dickson; L Beguinot; J A Hanover; N D Richert; M C Willingham; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

Review 4.  Fibronectin: a review of its structure and biological activity.

Authors:  E Pearlstein; L I Gold; A Garcia-Pardo
Journal:  Mol Cell Biochem       Date:  1980-02-08       Impact factor: 3.396

5.  The early appearance of fibronectin in the course of metastatic tumor growth in lymph nodes.

Authors:  D Lorke; P Möller
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

Review 6.  Fibronectin in cell adhesion and invasion.

Authors:  E Ruoslahti
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

7.  [Fibronectin].

Authors:  E Klar; D L Heene
Journal:  Klin Wochenschr       Date:  1984-10-15

8.  Cellular tumorigenicity in nude mice. Test of associations among loss of cell-surface fibronectin, anchorage independence, and tumor-forming ability.

Authors:  P Kahn; S I Shin
Journal:  J Cell Biol       Date:  1979-07       Impact factor: 10.539

9.  Suppression of malignancy in human cancer cells: issues and challenges.

Authors:  A B Sabin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

10.  Glucocorticoid hormone modulation of both cell surface and cytoskeleton related to growth control of rat glioma cells.

Authors:  M C Armelin; H A Armelin
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.